Consensus Envoy Medical, Inc.

Equities

COCH

US29415V1098

End-of-day quote Nasdaq Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
2.37 ^USD	-1.46%		-14.13%	+30.90%

05-15	Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000	MT
05-15	Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Envoy Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2af6a7f02f6c3699beb0.U9zcty7F2_Mirj38CAuJYsW-_b7tJ3gE6CA8ItL0q78.a7OzhX2EnJIUmH6UOGqwUbXmlMa_RU0zolB1EL2dzOkcsr7HYoKtylWYZA~87fa2b47a6bc4debe5f34e9053b42a15

Analyst Recommendations on Envoy Medical, Inc.

Lake Street Raises Price Target on Envoy Medical to $6 From $3, Maintains Buy Rating	04-03	MT
Northland Securities Initiates Envoy Medical at Outperform Rating, $5 Price Target	12-21	MT
Lake Street Initiates Envoy Medical at Buy Rating With $3 Price Target	11-28	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.37 USD

Average target price

5.5 USD

Spread / Average Target

+132.07%

High Price Target

6 USD

Spread / Highest target

+153.16%

Low Price Target

5 USD

Spread / Lowest Target

+110.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Envoy Medical, Inc.

Lake Street
Northland Securities

Quarterly revenue - Rate of surprise

Company calendar